R
Rapport Therapeutics, Inc. (RAPP)
NGM – Real Time Price. Currency in USD
47.73
-1.09 (-2.23%)
At close: Aug 12, 2026, 4:00 PM EDT
47.94
+0.21 (0.44%)
After-hours: Aug 12, 2026, 4:20 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
47.73
-1.09 (-2.23%)
At close: Aug 12, 2026, 4:00 PM EDT
47.94
+0.21 (0.44%)
After-hours: Aug 12, 2026, 4:20 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $63.7M significantly exceed its total debt $10.1M, ensuring strong financial flexibility
Total current assets $446.9M exceed Total current liabilities $28.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$41.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.72 | 6.05 | 10 | |
| Quick ratio | 15.72 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 20M |
| Gross Profit | -15K | -112K | -839K | -1M | 19M |
| Operating Income | -10M | -36M | -83M | -125M | -154M |
| Net Income | -11M | -35M | -78M | -111M | -137M |
| EBITDA | -10M | -36M | -82M | -124M | -153M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -69.99 | 1.0 |
| Next quarter | N/A | -68.59 | 1.0 |
| Current year | N/A | -41.31 | 1.0 |
| Next year | -100 | -22.25 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -185.1 | -183.32 | -215.9 | 1.0 |
| Y/Y | 999 | -111.78 | -58.66 | -65.51 | 3.3 |
| 3y average | 999 | -131.33 | N/A | -293.85 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |